We are pleased to announce that Jonathan Kalinski along with Ani Galyan (Galyan Law) will be speaking at an upcoming Strafford webinar on Tax Implications of Reclassifying Cannabis From a Schedule I to a Schedule III Drug, Tuesday, July 30, 2024, 10:00 a.m. – 11:30 a.m. (PST).
This webinar will provide tax professionals guidance on key tax implications of rescheduling cannabis from a Schedule I to a Schedule III drug. They will discuss the recent move by the Department of Justice to reclassify cannabis as a less harmful Schedule III drug under the Controlled Substances Act, its impact on federal and state-level taxation, Section 280E, and tax planning methods and reporting requirements for cannabis businesses under current tax law.
Click Here for More Information
For more information, please contact Jonathan Kalinski at kalinski@taxlitigator.com


Leave a comment